Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment

European Journal of Haematology

Volumn 70, Issue 4, 2003, Pages 231-234

  Baskaynak, Gökben ^a,b   Kreuzer, Karl Anton ^a   Schwarz, Michaela ^a   Zuber, Johannes ^a   Audring, Heike ^a   Riess, Hanno ^a   Dörken, Bernd ^a   Le Coutre, Philipp ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chronic myeloid leukemia; Glivec; Imatinib; Squamous cutaneous epithelial cell carcinoma

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSULFAN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HEMOGLOBIN; HYDROXYUREA; IMATINIB; MOLSIDOMINE; PANTOPRAZOLE; SPIRONOLACTONE;

AGED; ANAMNESIS; ARTHRALGIA; ARTICLE; BASOPHIL; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD TRANSFUSION; CANCER RISK; CASE REPORT; CEREBROVASCULAR ACCIDENT; CHROMOSOME 11; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL EXAMINATION; COMORBIDITY; DERMATITIS; DISEASE COURSE; DYSPNEA; EOSINOPHIL; HEMOGLOBIN DETERMINATION; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; ISCHEMIC HEART DISEASE; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIGHT EXPOSURE; LYMPHOCYTE; MALE; MONOCYTE; MUSCLE CRAMP; MUSCLE HYPERTONIA; MUSCLE WEAKNESS; MYALGIA; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCYTOPENIA; PRIORITY JOURNAL; PROMYELOCYTE; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS INFECTION; WART VIRUS; WOUND HEALING;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COCARCINOGENESIS; CORONARY DISEASE; DRUG ERUPTIONS; DYSPNEA; ENZYME INHIBITORS; FACIAL NEOPLASMS; HUMANS; HYDROXYUREA; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PANCYTOPENIA; PIPERAZINES; PLEURAL EFFUSION; PYRIMIDINES; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 0037398836     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00044.x     Document Type: Article

References (13)

1. KANTARJIAN H, SAWYERS C, HOCHHAUS A, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002;346:645-652.
2. TALPAZ M, SILVER RT, DRUKER B, et al. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia results of phase 2 study. Blood 2002;99:1928-1937.
3. SCHWARZ M, KREUZER K-A, BASKAYNAK G, DÖRKEN B and le COUTRE P. Imatinib induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia. Eur J Hematol 2002;69:254-256.
4. RAANANI P, GOLDMAN JM, BEN-BASSAT I. Depigmentation in a chronic myeloid leukemia patient treated with STI-571. J Clin Oncol 2002;20:869-870.
5. RINKER MH, FENSKE NA, SCALF LA, et al. Histologic variants of squamous cell carcinoma of the skin. Cancer Control 2001;8:354-363.
6. ALAM M, RATNER D. Cutaneous squamous-cell carcinoma. N Engl J Med, 2001;344:975-983.
7. MCMURRAY HR, NGUYEN D, WESTBROOK TF and MCANCE DJ. Biology of human papillomaviruses. Int. J. Exp. Path. 2001;82:15-33.
8. HARWOOD CA, PROBY CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 2002;15:101-114.
9. ANGELI-BESSON C, KOEPPEL MC, JACQUET P, ANDRAC L and SAYAG J. Multiple squamous-cell carcinomas of the scalp and chronic myeloid leukemia. Dermatology 1995;191:321-322
10. VASSALLO C, PASSAMONTI F, MERANTE S, ARDIGO M, NOLLI G, MANGIACAVA S and BORRONI G. Muco-cutaneous changes during long-therm therapy with hydroxyurea in chronic myloid leukaemia. Clin Exp Dermatol, 2001;26:141-148
11. SAKANO K, OIKAVA S, HASEGAWA K and KAWANISHI S. Hydroxyurea induces site-specific DNA damage via formation of hydrogen peroxide and nitric oxide. Jpn J Cancer Res 2001;92:1166-1174.
12. STOCKFLETH E, ULRICH C, MEYER T, ARNDT R and CHRISTOPHERS E. Skin diseases following organ transplantation-risk factors and new therapeutic approaches. Transplant Proc 2001;33:1848-1853.
13. CHANG WC, FUJIMIYA Y, CASTEEL N and PATFENGALE P. Natural killer cell immunodeficiency in patients with chronic myelogenous leukaemia. III. Defective interleukin-2 production by T-helper and natural killer cells. Int J Cancer 1989;43:591-597.